Pouget J-P, Chan TA, Galluzzi L, Constanzo J.
2023.
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.. Trends Cancer. 9(11):968-981.
Jbara A, Lin K-T, Stossel C, Siegfried Z, Shqerat H, Amar-Schwartz A, Elyada E, Mogilevsky M, Raitses-Gurevich M, Johnson JL et al..
2023.
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.. Nature. 617(7959):147-153.
Xu D, Forbes ANeil, Cohen S, Palladino A, Karadimitriou T, Khurana E.
2023.
Recapitulation of patient-specific 3D chromatin conformation using machine learning.. Cell Rep Methods. 3(9):100578.
Falvo DJ, Grimont A, Zumbo P, Fall WB, Yang JL, Osterhoudt A, Pan G, Rendeiro AF, Meng Y, Wilkinson JE et al..
2023.
A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas.. Dev Cell. 58(24):2959-2973.e7.
Matsubara N, de Bono J, Sweeney C, Chi KN, Olmos D, Sandhu S, Massard C, Garcia J, Chen G, Harris A et al..
2023.
Safety Profile of Ipatasertib Plus Abiraterone vs Placebo Plus Abiraterone in Metastatic Castration-resistant Prostate Cancer.. Clin Genitourin Cancer. 21(2):230-237.e1.
You J, Reilly MD, Eljalby M, Bareja R, Yusupova M, Vyas NS, Bang J, Ding W, Desman G, Miller LS et al..
2023.
Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.. Exp Dermatol. 32(7):1051-1062.
Geng C, Zhang M-C, Manyam GC, Vykoukal JV, Fahrmann JF, Peng S, Wu C, Park S, Kondraganti S, Wang D et al..
2023.
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.. Clin Cancer Res. 29(21):4464-4478.
Luo Y, Yamada M, N'Tumba-Byn T, Asif H, Gao M, Hu Y, Marangoni P, Liu Y, Evans T, Rafii S et al..
2023.
SPRY4-dependent ERK negative feedback demarcates functional adult stem cells in the male mouse germline†.. Biol Reprod. 109(4):533-551.
Wilczyñski JManuel Ort, Mena HAgustina, Ledesma MManuel, Olexen CMariel, Podaza E, Schattner M, Negrotto S, Errasti AEmilse, Silva EAntonio Ca.
2023.
The synthetic phospholipid C8-C1P determines pro-angiogenic and pro-reparative features in human macrophages restraining the proinflammatory M1-like phenotype.. Front Immunol. 14:1162671.
Steele MM, Jaiswal A, Delclaux I, Dryg ID, Murugan D, Femel J, Son S, Bois Hdu, Hill C, Leachman SA et al..
2023.
T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control.. Nat Immunol. 24(4):664-675.
Guilbaud E, Yamazaki T, Galluzzi L.
2023.
T cell-independent abscopal responses to radiotherapy.. Trends Cancer. 9(2):93-95.
Dantas E, Murthy A, Ahmed T, Ahmed M, Ramsamooj S, Hurd MA, Lam T, Malbari M, Agrusa C, Elemento O et al..
2023.
TIMP1 is an early biomarker for detection and prognosis of lung cancer.. Clin Transl Med. 13(10):e1391.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S et al..
2023.
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.. Cell Death Dis. 14(3):209.
Rustam S, Hu Y, Mahjour SBabak, Rendeiro AF, Ravichandran H, Urso A, D'Ovidio F, Martinez FJ, Altorki NK, Richmond B et al..
2023.
A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease.. Am J Respir Crit Care Med. 207(9):1171-1182.
Gregucci F, Spada S, Barcellos-Hoff MHelen, Bhardwaj N, Hak CChan Wah, Fiorentino A, Guha C, Guzman ML, Harrington K, Herrera FG et al..
2023.
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.. Oncoimmunology. 12(1):2222560.
Mendelson NL, Assaad MAl, Hadi K, Manohar J, Sigouros M, Sboner A, Medina-Martínez JS, Elemento O, Jessurun J, Mosquera JMiguel.
2023.
Whole-genome Analysis Elucidates Complex Genomic Events in GLI1 -rearranged Enteric Tumor.. Am J Surg Pathol. 47(10):1192-1193.